27777603|t|Angiotensin-converting enzyme insertion/deletion polymorphism association with obesity and some related disorders in Egyptian females: a case-control observational study
27777603|a|According to the WHO report in 2015, obesity is the fifth leading cause of death worldwide, and the prevalence of Egyptian female obesity is 37.5 %. Since obesity is highly influenced by genetics, and adipose tissue renin-angiotensin system is over-activated in obesity, the effect of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism on obesity and related disorders was studied in several populations, because of its effect on ACE activity. Our objective was to study the association of ACE I/D polymorphism with obesity and certain related disorders, namely hypertension, insulin resistance and metabolic syndrome, in Egyptian females. Eighty female volunteers were recruited, blood pressure and body measurements were recorded and a fasting blood sample was obtained for the quantitation of glucose, lipid profile, insulin, leptin and identification of ACE I/D polymorphs. Subjects were grouped based on hypertension and obesity states. Comparisons of continuous parameters were made with independent sample t-test between two groups. The frequencies of ACE genotypes and alleles, and the association between gene polymorphism and metabolic parameters were assessed using chi-square or Fisher's exact test. Genotype frequencies were in Hardy-Weinberg equilibrium for all groups. Genotype distribution did not differ significantly between controls and cases of all the studied disorders. Although DD carriers had apparently higher parameters of blood pressure, lipid profile and insulin resistance, only diastolic blood pressure was almost significant (p = 0.057). I-carriers were significantly less susceptible to hypertension than DD carriers having normal waist/hip ratio (p = 0.007, OR = 17.29, CI = 1.81-164.96) and normal conicity index (p = 0.024, OR = 7.00, CI = 1.36-35.93). In DD genotype carriers, a significant association was found between insulin resistance and high body mass index (p = 0.004, OR = 8.89, CI = 1.94-40.71), waist circumference (p = 0.003, OR = 9.63, CI = 2.14-43.36) and waist/height ratio (p = 0.034, OR = 6.86, CI = 1.25-37.61), although the variations in percentages between DD and I-carriers were not high enough to conclude an effect of ACE I/D on such an association. In this sample of Egyptian females, ACE I/D polymorphism was not significantly associated with obesity nor with any of its related disorders studied. The I allele seemed protective against hypertension in subjects with normal, not high, waist/hip ratio and conicity index compared to DD genotype carriers.
27777603	0	61	Angiotensin-converting enzyme insertion/deletion polymorphism	T033	C4015787
27777603	62	78	association with	T080	C0332281
27777603	79	86	obesity	T047	C0028754
27777603	104	113	disorders	T047	C0012634
27777603	117	125	Egyptian	T098	C0337801
27777603	126	133	females	T032	C0086287
27777603	137	169	case-control observational study	T062	C1518527
27777603	187	190	WHO	T093	C0043237
27777603	191	197	report	T170	C0684224
27777603	207	214	obesity	T047	C0028754
27777603	236	250	cause of death	T033	C0007465
27777603	251	260	worldwide	T079	C1254367
27777603	270	280	prevalence	T081	C0220900
27777603	284	292	Egyptian	T098	C0337801
27777603	293	299	female	T098	C0043210
27777603	300	307	obesity	T047	C0028754
27777603	325	332	obesity	T047	C0028754
27777603	343	353	influenced	T077	C4054723
27777603	357	365	genetics	T169	C0314603
27777603	371	385	adipose tissue	T024	C0001527
27777603	386	410	renin-angiotensin system	T022	C0035096
27777603	414	428	over-activated	T169	C0205245
27777603	432	439	obesity	T047	C0028754
27777603	445	454	effect of	T080	C1704420
27777603	455	528	angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism	T033	C4015787
27777603	532	539	obesity	T047	C0028754
27777603	552	561	disorders	T047	C0012634
27777603	585	596	populations	T098	C1257890
27777603	613	619	effect	T080	C1280500
27777603	623	635	ACE activity	T044	C2258685
27777603	641	650	objective	T170	C0018017
27777603	658	663	study	T062	C2603343
27777603	668	679	association	T080	C0439849
27777603	683	703	ACE I/D polymorphism	T033	C4015787
27777603	709	716	obesity	T047	C0028754
27777603	737	746	disorders	T047	C0012634
27777603	755	767	hypertension	T047	C0020538
27777603	769	787	insulin resistance	T046	C0021655
27777603	792	810	metabolic syndrome	T047	C0524620
27777603	815	823	Egyptian	T098	C0337801
27777603	824	831	females	T032	C0086287
27777603	833	839	Eighty	T081	C3816958
27777603	840	846	female	T098	C0043210
27777603	847	857	volunteers	T098	C0020155
27777603	874	888	blood pressure	T058	C3826646
27777603	893	910	body measurements	T060	C0203910
27777603	916	924	recorded	T169	C0205245
27777603	931	938	fasting	T033	C0015663
27777603	939	951	blood sample	T031	C0178913
27777603	973	985	quantitation	T081	C1709793
27777603	989	996	glucose	T109,T121,T123	C0017725
27777603	998	1011	lipid profile	T059	C0430044
27777603	1013	1021	insulin,	T116,T121,T125	C0021641
27777603	1022	1028	leptin	T116,T125	C0299583
27777603	1033	1047	identification	T080	C0205396
27777603	1051	1069	ACE I/D polymorphs	T033	C4015787
27777603	1071	1079	Subjects	T098	C0080105
27777603	1102	1114	hypertension	T047	C0020538
27777603	1119	1133	obesity states	T033	C4060989
27777603	1135	1146	Comparisons	T052	C1707455
27777603	1150	1160	continuous	T078	C0549178
27777603	1161	1171	parameters	T033	C0449381
27777603	1187	1198	independent	T078	C0085862
27777603	1199	1212	sample t-test	T170	C1709321
27777603	1225	1231	groups	T078	C0441833
27777603	1237	1248	frequencies	T081	C0017270
27777603	1252	1255	ACE	T116,T123	C1452534
27777603	1256	1265	genotypes	T032	C0017431
27777603	1270	1277	alleles	T028	C0002085
27777603	1287	1298	association	T080	C0439849
27777603	1307	1324	gene polymorphism	T045	C0678951
27777603	1329	1338	metabolic	T169	C0311400
27777603	1339	1349	parameters	T033	C0449381
27777603	1355	1363	assessed	T052	C1516048
27777603	1370	1380	chi-square	T170	C0008041
27777603	1384	1403	Fisher's exact test	T170	C1708064
27777603	1405	1413	Genotype	T032	C0017431
27777603	1414	1425	frequencies	T081	C0017270
27777603	1434	1460	Hardy-Weinberg equilibrium	T081	C1547026
27777603	1469	1475	groups	T078	C0441833
27777603	1477	1485	Genotype	T032	C0017431
27777603	1486	1498	distribution	T169	C1704711
27777603	1536	1544	controls	T096	C0009932
27777603	1549	1554	cases	T077	C1706256
27777603	1574	1583	disorders	T047	C0012634
27777603	1594	1605	DD carriers	T033	C0007294
27777603	1621	1627	higher	T080	C0205250
27777603	1628	1638	parameters	T033	C0449381
27777603	1642	1656	blood pressure	T040	C0005823
27777603	1658	1671	lipid profile	T059	C0430044
27777603	1676	1694	insulin resistance	T046	C0021655
27777603	1701	1725	diastolic blood pressure	T201	C0428883
27777603	1737	1748	significant	T078	C0750502
27777603	1762	1772	I-carriers	T033	C0007294
27777603	1797	1808	susceptible	T169	C0231204
27777603	1812	1824	hypertension	T047	C0020538
27777603	1830	1841	DD carriers	T033	C0007294
27777603	1849	1855	normal	T080	C0205307
27777603	1856	1871	waist/hip ratio	T032	C0205682
27777603	1884	1886	OR	T081	C0028873
27777603	1896	1898	CI	T081	C0009667
27777603	1918	1924	normal	T080	C0205307
27777603	1925	1939	conicity index	T034	C1254595
27777603	1952	1954	OR	T081	C0028873
27777603	1963	1965	CI	T081	C0009667
27777603	1984	2004	DD genotype carriers	T033	C0007294
27777603	2008	2019	significant	T078	C0750502
27777603	2020	2031	association	T080	C0439849
27777603	2050	2068	insulin resistance	T046	C0021655
27777603	2073	2093	high body mass index	T033	C0231254
27777603	2106	2108	OR	T081	C0028873
27777603	2117	2119	CI	T081	C0009667
27777603	2135	2154	waist circumference	T201	C0455829
27777603	2167	2169	OR	T081	C0028873
27777603	2178	2180	CI	T081	C0009667
27777603	2199	2217	waist/height ratio	T033	C1821269
27777603	2230	2232	OR	T081	C0028873
27777603	2241	2243	CI	T081	C0009667
27777603	2272	2282	variations	T070	C0042333
27777603	2286	2297	percentages	T081	C0439165
27777603	2306	2308	DD	T033	C0007294
27777603	2313	2323	I-carriers	T033	C0007294
27777603	2360	2369	effect of	T080	C1704420
27777603	2370	2377	ACE I/D	T033	C4015787
27777603	2389	2400	association	T080	C0439849
27777603	2410	2416	sample	T167	C0370003
27777603	2420	2428	Egyptian	T098	C0337801
27777603	2429	2436	females	T032	C0086287
27777603	2438	2458	ACE I/D polymorphism	T033	C4015787
27777603	2463	2480	not significantly	T033	C1273937
27777603	2481	2496	associated with	T080	C0332281
27777603	2497	2504	obesity	T047	C0028754
27777603	2533	2542	disorders	T047	C0012634
27777603	2556	2564	I allele	T028	C0002085
27777603	2591	2603	hypertension	T047	C0020538
27777603	2607	2615	subjects	T098	C0080105
27777603	2621	2627	normal	T080	C0205307
27777603	2639	2654	waist/hip ratio	T032	C0205682
27777603	2659	2673	conicity index	T034	C1254595
27777603	2686	2706	DD genotype carriers	T033	C0007294